argenx SE at Barclays Global Healthcare Conference Transcript
Hey, we'll make a start. So thank you, everyone, for joining us this afternoon. My name is Charles Pitman. I work on the European pharma team covering Mid-Cap pharma and life sciences stocks. And I'm very pleased to be joined today by Karl Gubitz, CFO of argenx.
Thank you, Charles. It's really great to be. Thank you for the conference.
Questions & Answers
Absolutely. And just starting with maybe a kind of overarching perspective on argenx. I know that you've originally had time at Pfizer, kind of large pharma background maybe if you could just start with talking about, you know, how the argenx approach differs, how the management team really worked together to ensure efficiency and what they're doing. And given you have so many things to be spend your money on balance that line between cost control and investment?
Yes, Thank
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
